Bagganahalli S. Somashekar

Bagganahalli S. Somashekar

Auto-generated profile, based on publicly available information

Bagganahalli S. Somashekar

Department of Biochemistry, CSIR-Central Food Technological Research Institute, KRS Road, Mysuru, 570020, India

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GTGirish Talakatta
Girish Talakatta
MSMohsen Sarikhani
Mohsen Sarikhani
JMJaseer Muhamed
Jaseer Muhamed
KDK. Dhanya
K. Dhanya
BSBagganahalli S. Somashekar
Bagganahalli S. Somashekar
Ravindra P VeerannaRavindra P Veeranna
Ravindra P Veeranna
In the long term, diabetes profoundly affects multiple organs, such as the kidney, heart, brain, liver, and eyes. The gradual loss of function in these vital organs contributes to mortality. Nonetheless, the effects of diabetes on the lung tissue are not well understood. Clinical and experimental data from our studies revealed that diabetes induces inflammatory and fibrotic changes in the lung. These changes were mediated by TGF-β-activated epithelial-to-mesenchymal transition (EMT) signaling pathways. Our studies also found that glucose restriction promoted mesenchymal-to-epithelial transition (MET) and substantially reversed inflammatory and fibrotic changes, suggesting that diabetes-induced EMT was mediated in part by the effects of hyperglycemia. Additionally, the persistent exposure of diabetic cells to high glucose concentrations (25 mM) promoted the upregulation of caveolin-1, N-cadherin, SIRT3, SIRT7 and lactate levels, suggesting that long-term diabetes may promote cell proliferation. Taken together, our results demonstrate for the first time that diabetes induces fibrotic changes in the lung via TGF-β1-activated EMT pathways and that elevated SMAD7 partially protects the lung during the initial stages of diabetes. These findings have implications for the management of patients with diabetes.

20 February 2008 in Journal of Coordination Chemistry
Verified
Journal Article
Closed access
YJY. Jadegoud
Y. Jadegoud
OIOmkar Ijare
Omkar Ijare
BSB. S. Somashekar
B. S. Somashekar
G. A. Nagana GowdaG. A. Nagana Gowda
G. A. Nagana Gowda
BMB. H. M. Mruthyunjayaswamy
B. H. M. Mruthyunjayaswamy
End-off compartmental pentadentate Schiff base, 2,6-bis[3′-methyl-2′-carboxamidyliminomethyl(6′,7′)benzindole]-4-methylphenol is synthesized and characterized by 2D NMR experiments and mass spectral techniques. The homodinuclear phenalato bridged end-off compartmental Schiff-base complexes Cu(II), Co(II), Ni(II), Mn(II), Fe(III), VO(IV), Zn(II), Cd(II) and Hg(II) have been prepared by the template method using the precursors 2,6-diformyl-4-methylphenol, 3-methyl(6′,7′)-2-benzindolehydrazide and metal chlorides in 1 : 2 : 2 ratio. The complexes are characterized by IR, NMR, UV-vis, FAB-mass, ESR and TGA techniques. Ni(II), Mn(II) and Fe(III) complexes have octahedral geometry, whereas the Cu(II), Co(II), VO(IV), Zn(II), Cd(II) and Hg(II) complexes have square pyramidal geometry. Low magnetic moment values for Cu(II), Co(II), Ni(II), Mn(II), Fe(III) and VO(IV) complexes indicate antiferromagnetic spin-exchange interaction between two metal centers. The metal complexes have been screened for their antibacterial activity against Escherichia coli and Staphyloccocus aureus and antifungal activity against Aspergillus niger and Fusarium oxysporum.